Seizert Capital Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-41,123
| Closed | -$1.02M | – | 191 |
|
|
2025
Q4 | $1.02M | Sell |
41,123
-102,174
| -71% | -$2.58M | 0.04% | 119 |
|
|
2025
Q3 | $3.65M | Buy |
143,297
+21,065
| +17% | +$520K | 0.16% | 96 |
|
|
2025
Q2 | $2.96M | Hold |
122,232
| – | – | 0.13% | 100 |
|
|
2025
Q1 | $3.1M | Buy |
+122,232
| New | +$3.2M | 0.14% | 98 |
|
|
2023
Q1 | – | Sell |
-5,090
| Closed | -$261K | – | 193 |
|
|
2022
Q4 | $261K | Sell |
5,090
-185
| -4% | -$8.87K | 0.01% | 183 |
|
|
2022
Q3 | $231K | Hold |
5,275
| – | – | 0.01% | 179 |
|
|
2022
Q2 | $277K | Sell |
5,275
-103
| -2% | -$5.25K | 0.01% | 191 |
|
|
2022
Q1 | $278K | Buy |
5,378
+645
| +14% | +$33.5K | 0.01% | 197 |
|
|
2021
Q4 | $279K | Buy |
+4,733
| New | +$235K | 0.01% | 194 |
|
|
2020
Q1 | – | Sell |
-24,809
| Closed | -$922K | – | 221 |
|
|
2019
Q4 | $922K | Sell |
24,809
-1,135
| -4% | -$40.4K | 0.05% | 135 |
|
|
2019
Q3 | $884K | Sell |
25,944
-1,475
| -5% | -$53.6K | 0.04% | 126 |
|
|
2019
Q2 | $1.13M | Sell |
27,419
-22,403
| -45% | -$890K | 0.06% | 129 |
|
|
2019
Q1 | $2.01M | Sell |
49,822
-338,792
| -87% | -$13.6M | 0.09% | 96 |
|
|
2018
Q4 | $16.1M | Sell |
388,614
-33,449
| -8% | -$1.39M | 0.73% | 53 |
|
|
2018
Q3 | $17.6M | Sell |
422,063
-43,038
| -9% | -$1.66M | 0.65% | 54 |
|
|
2018
Q2 | $15.7M | Hold |
465,101
| – | – | 0.57% | 55 |
|
|
2018
Q1 | $15.7M | Sell |
465,101
-7,251
| -2% | -$249K | 0.57% | 55 |
|
|
2017
Q4 | $16.2M | Buy |
472,352
+17,024
| +4% | +$580K | 0.58% | 54 |
|
|
2017
Q3 | $15.4M | Sell |
455,328
-54,070
| -11% | -$1.74M | 0.57% | 54 |
|
|
2017
Q2 | $16.2M | Sell |
509,398
-3,795
| -0.7% | -$120K | 0.59% | 55 |
|
|
2017
Q1 | $16.7M | Sell |
513,193
-15,037
| -3% | -$474K | 0.59% | 55 |
|
|
2016
Q4 | $16.3M | Sell |
528,230
-764,604
| -59% | -$23.3M | 0.58% | 54 |
|
|
2016
Q3 | $41.5M | Sell |
1,292,834
-115,873
| -8% | -$3.87M | 1.54% | 25 |
|
|
2016
Q2 | $47.1M | Sell |
1,408,707
-207,754
| -13% | -$6.63M | 1.78% | 15 |
|
|
2016
Q1 | $45.5M | Buy |
1,616,461
+319,000
| +25% | +$9.11M | 1.55% | 30 |
|
|
2015
Q4 | $39.7M | Sell |
1,297,461
-259,606
| -17% | -$8.17M | 1.24% | 35 |
|
|
2015
Q3 | $46.4M | Sell |
1,557,067
-319,432
| -17% | -$10.2M | 1.41% | 34 |
|
|
2015
Q2 | $59.7M | Sell |
1,876,499
-81,753
| -4% | -$2.66M | 1.52% | 24 |
|
|
2015
Q1 | $64.6M | Sell |
1,958,252
-570,648
| -23% | -$18.1M | 1.63% | 16 |
|
|
2014
Q4 | $74.7M | Sell |
2,528,900
-89,867
| -3% | -$2.58M | 1.58% | 19 |
|
|
2014
Q3 | $73.5M | Sell |
2,618,767
-11,972
| -0.5% | -$336K | 1.47% | 26 |
|
|
2014
Q2 | $74.1M | Buy |
2,630,739
+354,942
| +16% | +$10.1M | 1.47% | 24 |
|
|
2014
Q1 | $69.4M | Sell |
2,275,797
-141,880
| -6% | -$4.23M | 1.62% | 23 |
|
|
2013
Q4 | $70.3M | Sell |
2,417,677
-16,033
| -0.7% | -$467K | 1.66% | 20 |
|
|
2013
Q3 | $66.3M | Sell |
2,433,710
-197,624
| -8% | -$5.38M | 1.8% | 12 |
|
|
2013
Q2 | $69.9M | Buy |
+2,631,334
| New | +$72.7M | 1.9% | 17 |
|
Other funds holding PFE
VCM
VPM
Seizert Capital Partners's PFE Position: Q1 2026 in Review
Seizert Capital Partners sold out of Pfizer (PFE) in Q1 2026, closing a stake of 41,123 shares — an estimated $1.02M sold.
Seizert Capital Partners first reported a position in PFE in Q2 2013 and held it in 36 quarters. The position peaked at $74.7M in Q4 2014. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Seizert Capital Partners reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Seizert Capital Partners sold 41,123 Pfizer shares in Q1 2026, an estimated $1.02M.
- Seizert Capital Partners first reported a position in Pfizer in Q2 2013 and held it in 36 quarters.
- Seizert Capital Partners's Pfizer position peaked at $74.7M in Q4 2014.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Seizert Capital Partners's 13F filing for Q1 2026, filed 7 May 2026.